These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13332286)

  • 1. V.D.R.L. chancroid studies. II. Experimental chancroid in the rabbit.
    KAPLAN W; DEACON WE; OLANSKY S; ALBRITTON DC
    J Invest Dermatol; 1956 May; 26(5):407-14. PubMed ID: 13332286
    [No Abstract]   [Full Text] [Related]  

  • 2. V.D.R.L. chancroid studies. I. A simple procedure for the isolation and identification of Hemophilus ducreyi.
    DEACON WE; ALBRITTON DC; OLANSKY S; KAPLAN W
    J Invest Dermatol; 1956 May; 26(5):399-406. PubMed ID: 13332285
    [No Abstract]   [Full Text] [Related]  

  • 3. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
    Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T
    Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptomycin therapy in a case of sulfonamide-resistant Hemophilus ducreyi (chancroid) infection.
    WEBER WD; WILLIAMS JH; HUFFINES TR
    Am J Syph Gonorrhea Vener Dis; 1949 Jan; 33(1):58. PubMed ID: 18129457
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
    Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
    Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the biochemical reactions of Hemophilus ducreyi.
    REYMANN F
    Acta Pathol Microbiol Scand; 1949; 26(2):345-53. PubMed ID: 18126261
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
    Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
    Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and in situ cellular responses to Haemophilus ducreyi in the presence or absence of HIV infection.
    King R; Choudhri SH; Nasio J; Gough J; Nagelkerke NJ; Plummer FA; Ndinya-Achola JO; Ronald AR
    Int J STD AIDS; 1998 Sep; 9(9):531-6. PubMed ID: 9764937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Hemophilus ducreyi to antibiotic and other substances in vitro.
    MORTARA F; SAITO MT
    Am J Syph Gonorrhea Vener Dis; 1946 Jul; 30():352-60. PubMed ID: 20992351
    [No Abstract]   [Full Text] [Related]  

  • 12. The in vitro action of penicillin on Hemophilus ducreyi.
    TUNG T; FRAZIER CN
    Am J Syph Gonorrhea Vener Dis; 1945 Nov; 29():629-32. PubMed ID: 21005457
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chancroid: from clinical practice to basic science.
    Lewis DA
    AIDS Patient Care STDS; 2000 Jan; 14(1):19-36. PubMed ID: 12240879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens.
    Van Laer L; Vingerhoets J; Vanham G; Kestens L; Bwayo J; Otido J; Piot P; Roggen E
    Clin Exp Immunol; 1995 Nov; 102(2):243-50. PubMed ID: 7586673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.
    Hafiz S; Kinghorn GR; McEntegart MG
    Br J Vener Dis; 1981 Dec; 57(6):382-6. PubMed ID: 6976815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation.
    Yeung A; Cameron DW; Desjardins M; Lee BC
    J Microbiol Methods; 2011 Feb; 84(2):290-8. PubMed ID: 21185881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody: a preliminary evaluation.
    Karim QN; Finn GY; Easmon CS; Dangor Y; Dance DA; Ngeow YF; Ballard RC
    Genitourin Med; 1989 Dec; 65(6):361-5. PubMed ID: 2693334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans.
    Alfa MJ; Olson N; Degagne P; Slaney L; Plummer F; Namaara W; Ronald AR
    Sex Transm Dis; 1992; 19(6):309-14. PubMed ID: 1492255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.